Electrochemotherapy (ECT) in Patients With Primary Visceral Tumors and/or Secondary Visceral Localizations, of Any Histotype

This is an monocenter, single arm, clinical investigation that evaluate the impact of the method on the objective response rate (ORR) of visceral lesions undergoing electrochemotherapy. Electrochemotherapy is a well-defined method for the treatment of cutaneous and subcutaneous metastases of different tumor histotypes. Although still limited, the various experiences in the treatment of visceral localizations, particularly in liver metastases from colorectal cancer are promising and show that electrochemotherapy is a safe treatment, even in the case of lesions near large vessels or nerves. The

Trial Details

NCT ID
NCT06753136
Phase
NA
Sponsor
Istituto Oncologico Veneto IRCCS
Status
RECRUITING
Cancer Type
Melanoma
Interventions
  • percutaneous, laparoscopic or laparotomy lesion electrochemotherapy
Locations (sample)
  • Padova, Italy|44.38225,11.14261

Key Eligibility Criteria

  • Male/Female ≥ 18 years
  • Ability to understand the proposed treatment and express an informed acceptance by signing the informed consent
  • Diagnosis of primary and/or secondary visceral localizations of any histotype
  • Patients who are not eligible for standard curative procedures

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Melanoma Trials on Trialify →